PMM2-CDG T237M Mutation in a Patient with Cerebral Palsy-Like Phenotypes Reported from South India

Abstract

Congenital disorder of glycosylation (CDG) is an autosomal recessively inherited disorder. Hypotonia, stroke-like episodes, and peripheral neuropathy are also associated with the condition that typically develops during infancy. The patient, a 12-year-old girl born to healthy consanguineous parents, was diagnosed with cerebral palsy as a child. The affected patient has hypotonia, inadequate speech, strabismus, and developmental delay with mild mental retardation, which are key symptoms of CDG. Whole-exome sequencing (WES) identified the known missense pathogenic variant PMM2 c.710 C > T, p.T237M in the patient coding for the phosphomannomutase 2 (PMM2) confirming molecular testing of CDG. The patient's parents carried heterozygous PMM2 c.710 C > T variants. This study highlights the importance of WES in patients with a developmental disability or other neurological conditions, which is also useful in screening risk factors in couples with infertility or miscarriage issues.

Keywords

PMM2-CDG / cerebral palsy / mutation / South India

References

[1] Matthijs G, Schollen E, Bjursell C.et al.Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat 2000; 16(05) 386-394

[2] Barone R, Carrozzi M, Parini R.et al.A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J Neurol 2015; 262(01) 154-164

[3] Ganetzky R, Reynoso FJ, He M. Congenital disorders of glycosylation. In: Uttam Garg, Laurie D. Smith, Eds. Clinical Aspects and Laboratory Determination. 2017. Chapter 15; pp. 343-360

[4] Monin ML, Mignot C, De Lonlay P.et al.29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis 2014; 9(01) 207

[5] Lebredonchel E, Riquet A, Neut D.et al.A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report. Ital J Pediatr 2022; 48(01) 178

[6] Goreta SS, Dabelic S, Dumic J.Insights into complexity of congenital disorders of glycosylation. Biochem Med (Zagreb) 2012; 22(02) 156-170

[7] Chang IJ, He M, Lam CT.Congenital disorders of glycosylation. Ann Transl Med 2018; 6(24) 477

[8] 8 Sparks SE, Krasnewich DM. Congenital disorders of N-linked glycosylation and multiple pathway overview. GeneReviews®[Internet] 2017

[9] Altassan R, Péanne R, Jaeken J.et al.International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up. J Inherit Metab Dis 2019; 42(01) 5-28

[10] Park MJ, Yoo YJ, Chung CY, Hwang JM.Ocular findings in patients with spastic type cerebral palsy. BMC Ophthalmol 2016; 16(01) 195

[11] Pennefather PM, Tin W.Ocular abnormalities associated with cerebral palsy after preterm birth. Eye (Lond) 2000; 14(Pt 1): 78-81

[12] Yurdakul NS, Ugurlu S, Maden A.Strabismus in Down syndrome. J Pediatr Ophthalmol Strabismus 2006; 43(01) 27-30

[13] Jeon H, Jung J, Kim H, Yeom JA, Choi H.Strabismus in children with white matter damage of immaturity: MRI correlation. Br J Ophthalmol 2017; 101(04) 467-471

[14] Schiff M, Roda C, Monin ML.et al.Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature. J Med Genet 2017; 54(12) 843-851

[15] Citro V, Cimmaruta C, Monticelli M.et al.The analysis of variants in the general population reveals that PMM2 is extremely tolerant to missense mutations and that diagnosis of PMM2-CDG can benefit from the identification of modifiers. Int J Mol Sci 2018; 19(08) 2218

[16] Morgese MG, Trabace L.Maternal malnutrition in the etiopathogenesis of psychiatric diseases: role of polyunsaturated fatty acids. Brain Sci 2016; 6(03) 24

[17] Sully EA, Biddlecom A, Darroch JE.et al.Adding It Up: Investing in Sexual and Reproductive Health 2019. 2020. New York: Guttmacher Institute; Accessed May 2, 2023 at: https://www.guttmacher.org/report/adding-it-up-investing-in-sexual-reproductive-health-2019

[18] Rademaker D, Hukkelhoven CWPM, van Pampus MG. Adverse maternal and perinatal pregnancy outcomes related to very advanced maternal age in primigravida and multigravida in the Netherlands: a population-based cohort. Acta Obstet Gynecol Scand 2021; 100(05) 941-948

[19] Weinhold B.Environmental factors in birth defects: what we need to know. Environ Health Perspect 2009; 117(10) A440-A447

[20] Heinke D, Nestoridi E, Hernandez-Diaz S.et al; National Birth Defects Prevention Study. Risk of stillbirth for fetuses with specific birth defects. Obstet Gynecol 2020; 135(01) 133-140

[21] González-Domínguez CA, Raya-Trigueros A, Manrique-Hernández S.et al.Identification through exome sequencing of the first PMM2-CDG individual of Mexican mestizo origin. Mol Genet Metab Rep 2020; 25: 100637

RIGHTS & PERMISSIONS

2023 Global Medical Genetics